Trial Profile
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 22 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 23 Nov 2013 New trial record